Health Product Shortages homepage

Welcome to Health Product Shortages Canada, the website for mandatory reporting of health product shortages and discontinuations by regulated parties. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the health products they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca (opens in new window).

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

List of shortage reports
Brand name Company Name Status Strength Update Date Updated View Report
MYLAN-LANSOPRAZOLE MYLAN PHARMACEUTICALS ULC Anticipated shortage 15MG Updated Report 2026-03-17 278869
ANDROGEL BGP PHARMA ULC Anticipated shortage 1% Updated Report 2026-03-17 280137
MYLAN-RIVASTIGMINE PATCH 5 MYLAN PHARMACEUTICALS ULC Anticipated shortage 4.6MG Updated Report 2026-03-17 278875
MYLAN-VERAPAMIL SR MYLAN PHARMACEUTICALS ULC Actual shortage 120MG Updated Report 2026-03-17 278878
PYRIDOXINE HYDROCHLORIDE INJECTION, USP MYLAN PHARMACEUTICALS ULC Actual shortage 100MG Updated Report 2026-03-17 275921
MYLAN-NAPROXEN/ESOMEPRAZOLE MR MYLAN PHARMACEUTICALS ULC Actual shortage 20MG 375MG Updated Report 2026-03-17 280105
CLARUS MYLAN PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2026-03-17 278863
DILANTIN BGP PHARMA ULC Anticipated shortage 100MG Updated Report 2026-03-17 278286
VIAGRA BGP PHARMA ULC Actual shortage 25MG Updated Report 2026-03-17 275983
MAVIK BGP PHARMA ULC Actual shortage 2MG Updated Report 2026-03-17 278853

Discontinuation Reports

List of discontinuation reports
Brand name Company Name Status Strength Update Date Updated View Report
BORTEZOMIB FOR INJECTION SDZ SANDOZ CANADA INCORPORATED To be discontinued 3.5MG New Report 2026-03-16 280595
ANGIOMAX SANDOZ CANADA INCORPORATED To be discontinued 250MG New Report 2026-03-16 280590
ATIVAN PFIZER CANADA ULC Discontinued 1MG Updated Report 2026-03-13 269846
ATIVAN PFIZER CANADA ULC Discontinued 0.5MG Updated Report 2026-03-13 269843
RATIO-TOPISALIC TEVA CANADA LIMITED Discontinued 0.5MG 20MG New Report 2026-03-13 280453
Get it on Google Play Download on the App Store